Sensei Biotherapeutics GAAP每股收益为-16.72美元

2026-03-30 19:37

Sensei Biotherapeutics press release (SNSE): FY GAAP EPS of -$16.72.
Cash, cash equivalents and marketable securities were $21.2 million as of December 31, 2025 as compared to $41.3 million as of December 31, 2024.

More on Sensei Biotherapeutics

Sensei Biotherapeutics, Inc. (SNSE) Faeth Therapeutics, Inc. - M&A Call - Slideshow
Nano-cap biotech Sensei surges on $200M private placement, acquisition
Seeking Alpha’s Quant Rating on Sensei Biotherapeutics
Historical earnings data for Sensei Biotherapeutics
Financial information for Sensei Biotherapeutics